Ginger Wilson, Executive Director, Solid Tumors, US Medical Affairs Oncology at Jazz Pharmaceuticals, shared on LinkedIn:
“I’m excited to share an opportunity to join our US Medical Affairs Oncology Team at Jazz Pharmaceuticals as a Medical Director, GI Oncology and Solid Tumors.
This is a highly strategic role for a medical affairs professional who enjoys working across multiple tumor types, influencing strategy in a matrix environment, and helping advance innovative oncology programs across gastroesophageal adenocarcinoma (GEA), biliary tract cancer (BTC), and breast cancer.
If you’re interested or know someone who would be a great fit, I’d love to connect!”
You can also read:
Actio Biosciences Acquisition Strengthens Rare Epilepsy Research – Jazz Pharmaceuticals
